Works by Mathabe, Kgomotso

Results: 11

Ex vivo Vitamin D supplementation improves viscoelastic profiles in prostate cancer patients.

Published in:

Clinical Hemorheology & Microcirculation, 2022, v. 81, n. 3, p. 221, doi. 10.3233/CH-211353

By:

Hoek, Marinka;
Schultz, Michelle;
Alummoottil, Sajee;
Aneck-Hahn, Natalie;
Mathabe, Kgomotso;
Bester, Janette

Publication type:

Article

Many Voices in a Choir: Tumor-Induced Neurogenesis and Neuronal Driven Alternative Splicing Sound Like Suspects in Tumor Growth and Dissemination.

Published in:

Cancers, 2021, v. 13, n. 9, p. 2138, doi. 10.3390/cancers13092138

By:

Dlamini, Zodwa;
Mathabe, Kgomotso;
Padayachy, Llewellyn;
Marima, Rahaba;
Evangelou, George;
Syrigos, Konstantinos N.;
Bianchi, Arianna;
Lolas, Georgios;
Hull, Rodney;
Deckert, Marcel

Publication type:

Article

South African single surgeon experience: Comparison of oncological outcomes, robot‐assisted radical prostatectomy versus open perineal radical prostatectomy.

Published in:

International Journal of Urology, 2025, v. 32, n. 4, p. 423, doi. 10.1111/iju.15672

By:

Dlamini, Khayalethu C. S.;
Coetzee, Lance J.;
Mathabe, Kgomotso

Publication type:

Article

The South African guidelines on Enuresis--2017.

Published in:

African Journal of Urology, 2018, v. 24, n. 1, p. 1, doi. 10.1016/j.afju.2017.07.002

By:

Adam, Ahmed;
Claassen, Frederik;
Coovadia, Ashraf;
de Maayer, Tim;
Fockema, Margaret;
Fredericks, Joy;
Gottlich, Errol;
Grindell, Lizelle;
Haffejee, Mohamed;
Lazarus, John;
Levy, Cecil;
Mathabe, Kgomotso;
McCulloch, Mignon;
Moonsamy, Glenda;
Moshokoa, Evelyn;
Mutambirwa, Shingai;
Patel, Haroun;
van der Merwe, André;
Van Heerden, Izak;
Van Vijk, Frans

Publication type:

Article

Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 628, doi. 10.3390/ijms23020628

By:

Marima, Rahaba;
Hull, Rodney;
Mbeje, Mandisa;
Molefi, Thulo;
Mathabe, Kgomotso;
Elbagory, Abdulrahman M.;
Demetriou, Demetra;
Dlamini, Zodwa

Publication type:

Article

mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263618

By:

Sathekge, Mike;
Bruchertseifer, Frank;
Vorster, Mariza;
Lawal, Ismaheel O.;
Knoesen, Otto;
Mahapane, Johncy;
Davis, Cindy;
Mdlophane, Amanda;
Maes, Alex;
Mokoala, Kgomotso;
Mathabe, Kgomotso;
Van de Wiele, Christophe;
Morgenstern, Alfred

Publication type:

Article

mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263618

By:

Sathekge, Mike;
Bruchertseifer, Frank;
Vorster, Mariza;
Lawal, Ismaheel;
Knoesen, Otto;
Mahapane, Johncy;
Davis, Cindy;
Mdlophane, Amanda;
Maes, Alex;
Mokoala, Kgomotso;
Mathabe, Kgomotso;
de Wiele, Christophe Van;
Morgenstern, Alfred

Publication type:

Article

mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263618

By:

Sathekge, Mike;
Bruchertseifer, Frank;
Vorster, Mariza;
Lawal, Ismaheel;
Knoesen, Otto;
Mahapane, Johncy;
Davis, Cindy;
Mdlophane, Amanda;
Maes, Alex;
Mokoala, Kgomotso;
Mathabe, Kgomotso;
de Wiele, Christophe Van;
Morgenstern, Alfred

Publication type:

Article

mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263618

By:

Sathekge, Mike;
Bruchertseifer, Frank;
Vorster, Mariza;
Lawal, Ismaheel O.;
Knoesen, Otto;
Mahapane, Johncy;
Davis, Cindy;
Mdlophane, Amanda;
Maes, Alex;
Mokoala, Kgomotso;
Mathabe, Kgomotso;
Van de Wiele, Christophe;
Morgenstern, Alfred

Publication type:

Article

mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263618

By:

Sathekge, Mike;
Bruchertseifer, Frank;
Vorster, Mariza;
Lawal, Ismaheel O.;
Knoesen, Otto;
Mahapane, Johncy;
Davis, Cindy;
Mdlophane, Amanda;
Maes, Alex;
Mokoala, Kgomotso;
Mathabe, Kgomotso;
Van de Wiele, Christophe;
Morgenstern, Alfred

Publication type:

Article

mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263618

By:

Sathekge, Mike;
Bruchertseifer, Frank;
Vorster, Mariza;
Lawal, Ismaheel O.;
Knoesen, Otto;
Mahapane, Johncy;
Davis, Cindy;
Mdlophane, Amanda;
Maes, Alex;
Mokoala, Kgomotso;
Mathabe, Kgomotso;
Van de Wiele, Christophe;
Morgenstern, Alfred

Publication type:

Article

Works by Mathabe, Kgomotso

Ex vivo Vitamin D supplementation improves viscoelastic profiles in prostate cancer patients.

Many Voices in a Choir: Tumor-Induced Neurogenesis and Neuronal Driven Alternative Splicing Sound Like Suspects in Tumor Growth and Dissemination.

South African single surgeon experience: Comparison of oncological outcomes, robot‐assisted radical prostatectomy versus open perineal radical prostatectomy.

The South African guidelines on Enuresis--2017.

Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.

mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.

mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.